Lung Cancer Mutation Panel in UAE | 3000 AED | DHA Licensed Lab

Executive Summary & Core Metrics

Clinical Confidence, Delivered

The Lung Cancer Mutation Panel delivers 99.9% diagnostic sensitivity through ISO-accredited processing (ISO 9001:2015 Cert: INT/EGQ/2509DA/3139). This assay detects actionable mutations in EGFR, ALK, ROS1, and other key genes using dual-platform PCR and FISH. Results are delivered within 7 calendar days with a dedicated post-test telephonic consultation by a DHA-licensed specialist. Insurance verification is streamlined through WhatsApp at +971 54 548 8731.

Test Overview & Methodology

The Lung Cancer Mutation Panel identifies clinically actionable genetic mutations in tumour tissue using Polymerase Chain Reaction (PCR) and Fluorescence In-Situ Hybridization (FISH). It guides targeted therapy selection, helping oncologists tailor treatment plans based on the unique genomic profile of the lung tumour.

Feature	Our Lung Cancer Mutation Panel	Closest Alternative (External Hospital Lab)
Methodology	Dual-technology PCR + FISH (ISO 15189-aligned)	Single-method PCR or send-out NGS (variable QA)
Turnaround Time	Report within 7 days (Sample Tue, Report Mon)	10–14 working days, often without weekend processing
Sample Logistics	Secure Medical Courier Solid Tissue Specimen Retrieval; FFPE block/slides accepted	Hospital drop-off only; no retrieval service
Clinical Support	Post-test tele-guidance by DHA-licensed oncologist	Report only; no integrated consultation
Insurance Assistance	Direct billing verification via WhatsApp	Manual pre-approval required

Physician Insight & Safety Protocols

“Molecular testing must be interpreted in the full clinical context. A positive EGFR, ALK, or ROS1 mutation can open the door to highly effective targeted therapy, but a negative panel does not rule out malignancy. Always integrate imaging and histopathology.”

— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA ID 61713011

Advisory – Medication & Test Integration

⚠️ Do not alter or discontinue any prescribed therapy without consulting your treating physician. Test results should be reviewed alongside clinical and radiological findings for comprehensive management.

Exclusion Criteria & Red Flags

Specimen Rejection: Inadequate tumour content (<20%), decalcified tissue, or non-formalin-fixed specimens will not be processed.
Missing Documentation: Fully completed Form 20 (Genomics Requisition) is mandatory; samples without it cannot be accepted.
Clinical Emergency Signs: Sudden chest pain, severe shortness of breath, or coughing up blood require immediate emergency care.
Paediatric Note: For minors, parental consent and paediatric oncology referral are required as per UAE law.

Patient FAQ & Clinical Guidance

1. What is the Lung Cancer Mutation Panel and why is it performed?

The panel identifies specific gene changes in lung tumour tissue to guide personalised targeted therapy, such as EGFR inhibitors, ALK inhibitors, and ROS1 inhibitors.

2. How should I prepare for sample collection?

No special preparation is needed as the test uses previously collected tumour tissue. Ensure your physician submits a completed Form 20 and provides the FFPE block or slides.

3. How long does it take to receive the results?

Results are available within 7 calendar days after the laboratory receives the specimen, with a detailed clinical interpretation included.

UAE Regulatory & Data Privacy Adherence

This service complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent and clinical safety are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. All genomic data is handled in strict confidence and stored on secure, audited servers within the UAE.

Clinical & Logistical Metadata

Test Name	Lung Cancer Mutation Panel (EGFR, ALK, ROS1, and others)
Price (AED)	3,000 AED
Turnaround Time	7 calendar days from sample receipt at laboratory
Sample Type / Matrix	Archival Tissue Specimen – Formalin-fixed paraffin-embedded (FFPE) tumour block or slides. Secure Medical Courier Solid Tissue Specimen Retrieval.
Methodology Used	Polymerase Chain Reaction (PCR) and Fluorescence In-Situ Hybridization (FISH)
ICD-10-CM Code	C34.90
LOINC Code	51968-1
DHA Facility License & Address	License No. 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. Operated by DNA Labs UAE.